Drug Therapy
Article
Opioid use disorder in adolescents: An overview
Treatment needs to include interventions that address young patients’ unique needs.
Reports From the Field
Improving Nephropathy Screening in Appalachian Patients With Diabetes Using Practice-Wide Outreach
Outcomes Research in Review
Switching from TDF- to TAF-Containing Antiretroviral Therapy: Impact on Bone Mineral Density in Older Patients Living With HIV
News
ECHELON-1 update: A+AVD bests ABVD in Hodgkin lymphoma
FDA/CDC
FDA okays Palforzia, first drug for peanut allergy in children
Palforzia will carry a boxed warning on the risk of anaphylaxis, and initial doses can be given only by certified professionals in certified...
Conference Coverage
Gestational diabetes: Treatment controversy rages on
WASHINGTON –
News
High-dose chemo offers survival benefit only for highest-risk breast cancer
Women with 10 or more involved axilliary nodes or triple-negative breast cancer had a 20-year overall survival benefit from high-dose chemotherapy...
News
Psoriasis: A look back over the past 50 years, and forward to next steps
“The progress has been breathtaking – there’s no other way to describe it.”
Conference Coverage
Dual immunotherapy goes the distance in MSI-H colorectal cancer
SAN FRANCISCO – At a median follow-up of almost 20 months, combination nivolumab and ipilimumab remained highly active as first-line therapy for...
Conference Coverage
What 2019’s top five CAD trials tell us
SNOWMASS, COLO. – Triple therapy as a triple threat – a three-pronged threat to patient safety, Dr. Malcolm R. Bell says.